7821 - 7830 of 8587 Results
Title
Year
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,17End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
-
RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,20End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
-
RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0
-
RESTRICTEDTitle: Novel Genes May Drive Progression in Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 12Start Page: 25End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1Citation Count: 0
- The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and Prevention2021RESTRICTEDTitle: The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and PreventionJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 9Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000752844.66769.73Citation Count: 0
-
OPENTitle: Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000001043Best OA location URL: http://hdl.handle.net/2066/238509Citation Count: 7
-
RESTRICTEDTitle: Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020Journal Name: Operative NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 5Start Page: 277End Page: 290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/ons/opab261Citation Count: 16
-
OPENTitle: Orofacial pain in 1916 patients with early or moderate Parkinson diseaseJournal Name: PAIN ReportsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 1Start Page: e923End Page: e923Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1097/pr9.0000000000000923Best OA location URL: https://doi.org/10.1097/pr9.0000000000000923Citation Count: 11
- Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease2021OPENTitle: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel diseaseJournal Name: Pharmacogenetics and GenomicsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 32Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8578201Citation Count: 4